These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23763406)

  • 21. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reimbursement of opiate substitution drugs to militaries in 2007].
    d'Argouges F; Desjeux G; Marsan P; Thevenin-Garron V
    Encephale; 2012 Sep; 38(4):304-9. PubMed ID: 22980471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.
    Awgu E; Magura S; Rosenblum A
    J Psychoactive Drugs; 2010 Sep; 42(3):339-46. PubMed ID: 21053756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Substitution study. Is it allowed to give placebos to junkies?].
    Ullmann R
    MMW Fortschr Med; 2003 Jul; 145(27-28):13. PubMed ID: 14587179
    [No Abstract]   [Full Text] [Related]  

  • 26. Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.
    Schwartz RP; Kelly SM; Gryczynski J; Mitchell SG; O'Grady KE; Jaffe JH
    J Addict Dis; 2015; 34(2-3):151-61. PubMed ID: 26079104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study: Re: Meyer et al.
    McCarthy JJ
    J Addict Med; 2016; 10(2):133-4. PubMed ID: 26985649
    [No Abstract]   [Full Text] [Related]  

  • 29. Medicines for Patients After an Opioid Overdose.
    Ann Intern Med; 2018 Aug; 169(3):. PubMed ID: 29913484
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessing need for medication-assisted treatment for opiate-dependent prison inmates.
    Albizu-García CE; Caraballo JN; Caraballo-Correa G; Hernández-Viver A; Román-Badenas L
    Subst Abus; 2012; 33(1):60-9. PubMed ID: 22263714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study.
    Abrahamsson T; Berge J; Öjehagen A; Håkansson A
    Drug Alcohol Depend; 2017 May; 174():58-64. PubMed ID: 28315808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors impeding switching from methadone to buprenorphine in heroin users receiving methadone maintenance therapy - A naturalistic cohort study.
    Chung KS; Wu HC; Hsu CY; Lu YS; Li DJ
    J Subst Abuse Treat; 2019 Oct; 105():51-56. PubMed ID: 31443892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?
    Garcia-Portilla MP; Bobes-Bascaran MT; Bascaran MT; Saiz PA; Bobes J
    Br J Clin Pharmacol; 2014 Feb; 77(2):272-84. PubMed ID: 23145768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid Use Disorder and Pregnancy.
    O'Donnell FT; Jackson DL
    Mo Med; 2017; 114(3):181-186. PubMed ID: 30228577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effectiveness and safety of methadone maintenance.
    Ward J; Mattick RP; Hall W; Darke S
    Addiction; 1996 Nov; 91(11):1727-9. PubMed ID: 8972930
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcome of heroin-dependent adolescents presenting for opiate substitution treatment.
    Smyth BP; Fagan J; Kernan K
    J Subst Abuse Treat; 2012 Jan; 42(1):35-44. PubMed ID: 21940134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year mortality rates following methadone treatment discharge.
    Zanis DA; Woody GE
    Drug Alcohol Depend; 1998 Nov; 52(3):257-60. PubMed ID: 9839152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
    Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
    Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.